APYX Apyx Medical Corporation
Apyx Medical Corporation, an energy technology company, designs, develops, manufactures, and sells electrosurgical equipment and medical devices in the United States and internationally. The company operates through two …
Industry Peers
Medical Devices| Headline | Source | Time |
|---|---|---|
Older | ||
 Apyx Medical (APYX) Q2 2026 Earnings Call Transcript AYON adoption accelerated 22% as surgeons target GLP-1 weight-loss patients. | ||
 Apyx Medical Sees GLP-1 Boom Fueling Demand for Renuvion, AYON Body Contouring Apyx Medical (NASDAQ:APYX) is positioning its Renuvion technology and newly launched AYON Body Contouring System to address growing demand for surgical aesthetic procedures, a trend CEO Charlie Goodwin said has been reshaped by the increasing use of GLP-1 weight-loss drugs. Speaking at the Canaccor | ||
Apyx Medical Corp (APYX) (Q2 2026) Earnings Call Highlights: Revenue Surges 22% on Power Lipo ... Company capitalizes on expanded FDA clearance and growing body contouring demand, reaffirming full-year guidance despite margin headwinds. | ||
 Apyx Medical (APYX) Reports Q2 Loss, Beats Revenue Estimates Apyx (APYX) delivered earnings and revenue surprises of -16.67% and +10.37%, respectively, for the quarter ended June 2026. Do the numbers hold clues to what lies ahead for the stock? | ||
 Apyx Medical Q2 Earnings Call Highlights Apyx Medical (NASDAQ:APYX) reported second-quarter revenue growth of 22% as sales in its surgical aesthetics business increased, led by adoption of its AYON Body Contouring System, international generator sales and domestic demand for single-use handpieces. Total revenue for the quarter ended June | ||